The medical care deputy of the Social Security Organization (SSO), Mr. Ali Fattahi, said that if the Supreme Insurance Concil (Shoraye Ali Bimeh) approves a suggested official plan to financially protect the cost of treatment for patients undergoing hemodialysis, hemophiliacs, and thalassemia patients (so called privileged medical conditions or Bimari-haye Khas in Farsi), these patients will not have to pay for expensive medicines. The SSO now pays the total cost of medicines for 8,153 of such payments he added. The plan says that patients should pay a co-payment for cheaper drugs while the insurers pay 100% of costs of expensive medicines. The SSO covers 85% of costs of medicines for patients with cancers although cancers have not been listed as so called privileged medical conditions , Mr. Fattahi said. 3,562 patients with multiple sclerosis (MS) are being financially protected by the SSO he said but he did not specify the percentage of medical cost coverage by the SSO for these patients.
Source: www.jamejamonline.ir , Feb, 7 2007
Code: 23N
I created this blog to share with you my concerns about healthcare system in Iran as an example of a developing country. I would like you to feedback on the major challenges of the healthcare system in Iran. Healthcare disparity, quality, and status of healthcare are among subjects I am very interested to write about. I hope this blog makes researchers and policymakers in the field more familiar with the healthcare system of this country.
Showing posts with label privilidged patients. Show all posts
Showing posts with label privilidged patients. Show all posts
Sunday, February 11, 2007
Subscribe to:
Posts (Atom)